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Review Article
Objectives: Timely prehospital diagnosis and treatment of acute coronary 
syndrome (ACS) are required to achieve optimal outcomes. Clinical decision 
support systems (CDSS) are platforms designed to integrate multiple data 
and can aid with management decisions in the prehospital environment. The 
review aim was to describe the accuracy of CDSS and individual components 
in the prehospital ACS management.
Methods: This systematic review examined the current literature regarding 
the accuracy of CDSS for ACS in the prehospital setting, the influence of 
computer-aided decision-making and of 4 components: electrocardiogram, 
biomarkers, patient history, and examination findings. The impact of these 
components on sensitivity, specificity, and positive and negative predictive 
values was assessed.
Results: A total of 11,439 articles were identified from a search of databases, 
of which 199 were screened against the eligibility criteria. Eight studies 
were found to meet the eligibility and quality criteria. There was marked 
heterogeneity between studies which precluded formal meta-analysis. 
However, individual components analysis found that patient history led 
to significant improvement in the sensitivity and negative predictive 
values. CDSS which incorporated all 4 components tended to show higher 
sensitivities and negative predictive values. CDSS incorporating computer-
aided electrocardiogram diagnosis showed higher specificities and positive 
predictive values.
Conclusions: Although heterogeneity precluded meta-analysis, this review 
emphasizes the potential of ACS CDSS in prehospital environments that 
incorporate patient history in addition to integration of multiple components. 
The higher sensitivity of certain components, along with higher specificity of 
computer-aided decision-making, highlights the opportunity for developing 
an integrated algorithm with computer-aided decision support.
Key Words: acute coronary syndrome, algorithm, clinical decision support 
systems, diagnosis, emergency medical services
(Crit Pathways in Cardiol 2020;19: 119–125)
Despite a decline in coronary heart disease deaths by more than 50% between 1961 and 2016, coronary heart disease is still 
a leading cause of mortality in the United Kingdom.1 In Scotland, 
acute coronary syndrome (ACS) is a major cause of mortality with 
6697 deaths in 2016.2 ST elevation myocardial infarction (STEMI) 
is the most acutely critical subtype of ACS with highest 30-day 
mortality.3–5 Time is critical for STEMI management as mortality 
increases with treatment delays.4,6 Prehospital STEMI identification 
has been shown to reduce treatment delays and improve mortality.7,8
The importance of timely prehospital recognition of STEMI is 
well established,7 yet there are still recognized difficulties. Prehospital 
difficulties include the absence of complete medical records and lack 
of diagnostic support tools, such as imaging, which increases the risk 
of ACS misdiagnosis and creates a low positive predictive value for 
prehospital ACS diagnosis.9 A low positive predictive value increases 
inappropriate treatment of ACS including cardiac catheterization lab-
oratory (“cath-lab”) activation.10 Over activation of the cath-lab is a 
potentially avoidable strain on a valuable clinical resource. False mo-
bilization increases workload of the cath-lab team and often requires 
unnecessary redirection of emergency medical services to deliver 
patients to cath-lab centers outside their normal operating zones.
Conversely, under diagnosis of STEMI has obvious negative 
consequences. Delayed presentation of STEMI has significantly 
decreased long-term survival rates (73% survival with late presenters 
vs. 93% survival with early presenters)11 and even late treatment of 
STEMI via reperfusion of the culprit occluded artery has no benefit 
in mortality compared to conservative medical therapy.12 In addition, 
subtypes of ACS such as non-ST–elevation myocardial infarction 
(NSTEMI) and unstable angina can be just as critical as a STEMI 
as ST elevation on the electrocardiogram (ECG) is not exclusive for 
acute coronary artery occlusion,13 that is, a proportion of NSTEMI 
are actually caused by an occluded coronary artery.
Clinical decision support systems (CDSS) are platforms that 
combine multiple clinical data inputs (termed “components” in this 
review) to produce a single output, which can be a diagnosis, clinical 
advice or risk stratification, that can help clinicians with difficult de-
cision-making.9 For instance, CDSS have already been developed for 
use in the emergency department for ACS,14,15 where these tend to 
focus on a high negative predictive value to prioritize safe discharge. 
In the community, there is increased difficulty for out-of-hospital 
practitioners, like general practitioners (especially those in remote 
and rural communities) and ambulance crews, to make triage deci-
sions in patients with ACS without the clinical diagnostic tools that 
are available in the hospital. These difficulties are compounded with 
suspected ACS that presents without obvious ST elevation as a non-
diagnostic ECG creates further ambiguity. This challenge has been 
the target of CDSS-related research to assist prehospital clinicians to 
manage patients who have suspected ACS.16
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With great interrogation of technology in healthcare, there is a 
large potential for computer-aided diagnosis of ACS in the prehospital 
setting. Computer-aided decision support has already been shown to be 
beneficial determining allocation for level of life support in the emer-
gency department.17 In addition, computer-aided ECG interpretation 
algorithms have been developed to improve prehospital and emergency 
department ACS identification to reduce the delay or misdiagnosis of 
ACS associated with prolonged door-to-balloon time.18
However, computer-aided ECG interpretation is still limited 
by ECG artifact and other nonischemic causes of ST elevation such 
as early-repolarization and thus interpretation of the ECG should be 
done in combination of other components such as symptoms and 
medical history.19,20
In the prehospital environment, there are concerns that CDSS 
can cause delays compared to standard care9 and that these systems 
might reduce the autonomy of clinicians.21 However, previous studies 
have shown the benefit of prehospital CDSS for patients with stroke22 
and spinal injury.23 One review looked at prehospital CDSS for ACS 
but excluded tests using computer-aided decision systems and bio-
marker tests.24 With advances in computer technology and point-of-
care testing, the use of these components is now increasingly realistic 
in a prehospital setting.
The aim of this systematic review was to describe the accuracy 
of CDSS and their individual components in the prehospital manage-
ment of ACS.
METHODS
The search strategy followed the guidelines set by the preferred 
reporting items for systematic review and meta-analysis.25 The review 
protocol was designed with guidance from the preferred reporting 
items for systematic review and meta-analysis protocol statement and 
was registered with Prospero (registration number: 116600).26
Search Strategy
The search strategy was designed and executed by the first au-
thor. Five databases were searched: EMBASE, Medline, Cochrane 
Library, Web of Science, and CINAHL. The searches were per-
formed between December 2018 and January 2019. Grey literature 
was also reviewed for any additional sources. The search terms used 
are in Appendix 1 (supplemental material, available at http://links.
lww.com/HPC/A216).
Study Selection and Eligibility
Abstracts and titles were screened and selected if they were 
adjudged to be relevant to the review aim. Duplicates were excluded. 
The review focused on the use of CDSS in a prehospital setting where 
patients presented with symptoms suggestive of ACS. Definitions for 
ACS included STEMI, NSTEMI, or unstable angina as per European 
Society of Cardiology  guidelines.27 Prehospital was defined as con-
tact with first emergency responders (including paramedics, med-
ical dispatch callers, general practitioners). Studies carried out in 
the hospital environment or emergency department were excluded. 
Patient history was defined as subjective symptoms reported by the 
patient (eg, chest pain, shortness of breath, and clamminess), while 
vital signs/examination were defined as objective noninvasive clin-
ical measurements obtained by clinical staff (eg, heart rate, blood 
pressure, and oxygen saturations).
Inclusion criteria were as follows:
1. Published source
2. Data on patient diagnosis or outcome such as major ad-
verse cardiovascular events
3. Set in a prehospital setting
4. Use of CDSS as an intervention
5. Patients with suspected ACS
6. English language
Exclusion criteria were as follows:
1. No data on outcomes
2. Inclusion of emergency department/inhospital decision aids
3. Inclusion of nonsuspected ACS patients
4. No definition of myocardial infarction (MI)
5. Not in English language
Full-text versions of the papers selected were obtained and analyzed. 
Papers were then included or excluded based on the criteria. A second 
reviewer judged the selection process and analyzed the eligible pa-
pers separately by the criteria for consensus. Any disagreements were 
resolved by discussion between the 2 reviewers to reach a consensus. 
Cohen’s kappa coefficient was performed between the reviewers to 
analyze the rate of agreement.
Assessment of Quality and Risk of Bias
Quality assessment was conducted using a quality assessment 
tool for diagnostic accuracy studies (QUADAS).28 Articles were ana-
lyzed to ensure there was no obvious missing data and that patients 
progressed through the study as described. Studies were excluded 
from analysis where there was a high or unclear risk of bias. They 
were then ranked according to level of evidence as determined by 
published hierarchy of evidence, which takes into account any vali-
dation and impact analysis of CDSS.29
Data Extraction
Data were extracted using a data extraction tool that was 
piloted with 2 initial studies and subsequently refined. The data types 
that were extracted are outlined in Appendix 2 (supplemental mate-
rial, available at http://links.lww.com/HPC/A216). The primary out-
come recorded from studies was a final diagnosis of ACS accuracy.
Data Analysis
Data analysis was performed using statistical analysis software 
SPSS 24.0 (SPSS Inc., Chicago, IL). The sensitivity, specificity, and pos-
itive and negative predictive value of CDSS were examined. The results 
were reported as percentages and analyzed as continuous data. Whether 
a history, examination/vital signs, ECG, and biomarker components 
were included in the study, then this was described as binary (yes or no) 
and treated as categorical data. Independent-samples t test was used to 
analyze the difference of mean accuracy (percentage) between CDSS 
with and without components. A P value ≤0.05 was considered to be sta-
tistically significant. Because of the considerable heterogeneity between 
the papers selected, formal meta-analysis was deemed not possible.
RESULTS
Study Selection and Quality Assessment
Figure 1 outlines the search and selection process for this review. 
The titles and abstracts for 11,439 articles were screened. A total of 199 
articles were initially identified through this process and reviewed. Of 
these, 182 articles did not fulfill eligibility criteria, leaving 17 articles.
The studies were assessed for their quality using the QUADAS 
2 tool.28 Four studies were rejected from the study due to high risk 
of bias. A further 5 studies were assessed to have some minimal or 
moderate bias, all with patient selection, as would be expected with 
nonrandomized prospective and observational studies.20,30–33 Only 2 
studies had validation phases for their CDSS and there was no impact 
analysis with any of the 17 articles thus undermining of the potential 
quality of evidence as judged by the predefined hierarchy.31,33 Ideally, 
validation and impact analysis would be required before any CDSS 
could be judged suitable for implementation in other health localities. 
The second reviewer screened the 17 selected studies and Cohen’s 
kappa coefficient for interobserver agreement between the 2 review-
ers was calculated at k = 0.46, which equates to moderate agreement. 
Following collaboration with the second reviewer and QUANDAS 2 
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tool quality control, 9 studies from the 17 were excluded, leaving 8 
studies that were included in the analysis.16,20,30–35
Study Characteristics
Seven of the 8 studies were prospective in nature, with use 
of CDSS performed “on-site” by a general practitioner, emergency 
medical services staff, or medical dispatcher.16,30–35 Two studies were 
retrospective analyses of patients and included either computer-aided 
ECG interpretation or decision-making.20,34 Table 1 displays the dem-
ographic characteristics of the patients in the 8 studies. A total of 
354,259 patients were in the studies combined; however, 1 study 
contributed 347,989 patients making up 98% of the total population. 
The average number of patients excluded was 69, the majority being 
from 1 study which only had data on 15% of patients.30 Mean age 
was 65 years and 54% of participants were male. Half of the studies 
were conducted in the Netherlands, with a further 2 in the United 
States and the remainder in Sweden and Japan. Five studies involved 
emergency medical services, 2 involved general practitioners, and 1 
involved a medical call dispatch team.
Heterogeneity
There was a large degree of heterogeneity in the 8 studies. 
The first study was published in 1996, and the last 22 years later in 
2018.16,33 As noted above, 7 of the studies were prospective and 1 was 
retrospective in design. The composition of the CDSS components 
differed, with 7 studies involving patient history16,30–35; 6 involving 
prehospital ECG interpretation16,20,31,33–35; 5 involving examination 
and vital signs16,31–33,35; and 2 involving a prehospital biomarker 
test.16,35 The last 2 studies were the only ones to develop CDSS that 
incorporated all 4 components.16,35 With regards to the outcomes 
measured, 3 reported ACS (MI including unstable angina)30,32,33; 3 
others reported STEMI20,31,34; 1 reported NSTEMI16; and 1 reported 
a major adverse cardiovascular event35(defined as any MI, primary 
PCI, coronary artery bypass graft or any cause of mortality). The 
definition of MI also differed between studies, with 330,32,34 using 
the universal guidance on the diagnosis of MI,36 2 other studies16,35 
used the third universal definition of MI,37 while the final 3 used a 
combination of ECG findings, biomarkers, and history to diagnose 
ACS.20,31,33 The incidence of the ACS also was widely different be-
tween the studies, ranging from 0.02% to 50%.
Statistical Analysis
The results of the analysis of the outcomes, sensitivities, spec-
ificity, positive predictive value, and negative predictive value of the 
studies are described in Table 2. The sensitivity between the studies 
varied from 100% to 58%, with specificity varying from 100% to 
10%, positive predictive value between 100% and 7%, and negative 
predictive value between 100% and 30%. Table 3 shows that only the 
inclusion of patient history was found to have a significant impact 
on improving accuracy of sensitivity and negative predictive value 
of CDSS.
DISCUSSION
The utility of CDSS for ACS in prehospital settings is yet to be 
established. This systematic review of the literature, the first to be con-
ducted on the topic, found considerable variations in the components 
of CDSS that were examined in existing studies. The extent of the het-
erogeneity precluded a formal meta-analysis; however, a comparison 
of which components were key in successful CDSS was performed.
This review found that the use of the patient history compo-
nent in CDSS remains highly important in diagnosis with significant 
improvement on the sensitivity (P = 0.002) and negative predictive 
value (P < 0.001). These findings highlight the potential of CDSS 
that incorporate patient history in a “rule-out” capacity for an ACS 
FIGURE 1. Flow chart of literature search and selection process.
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diagnosis. The significant impact of patient history in this review 
may have been due to patient history being the most prevalent tool in 
CDSS with it being included in 7 of the 8 studies reviewed.16,30–35 In 
comparison, prehospital ECG was used in 6 of the 8 studies,16,20,31,33–35 
vital signs and examinations were used in 5 studies,16,31–33,35 and bio-
markers were used in just 2 studies.16,35
Interestingly, in the 2 studies16,35 that used all 4 components 
(the ECG, a point-of-care biomarker, patient history, and vital signs/
examinations), both achieved high sensitivity (100% and 96%) and 
negative predictive value (100% and 97%) but poor specificity (43% 
and 29%) and positive predictive value (29% and 21%). However, 
both studies excluded patients with clear ST elevation, thus focusing 
on the risk stratification of patients between ACS and non-ACS 
rather than triage of patients with NSTEMI or STEMI. Three of the 
studies20,31,34 looked exclusively at the identification of STEMI and 
had a larger range of specificity (88%–100%) and positive predictive 
value (7%–100%). The heterogeneity of the findings appears to be 
dependent on the aim of a prehospital CDSS to differentiate between 
a “rule-in/out” for ACS or between NSTEMI and STEMI.
Recent advances have allowed the use of high-sensitivity tro-
ponins to achieve a high degree of sensitivity in the diagnosis of ACS, 
leading to the reduction of unstable angina diagnosis.38 One of the 
studies reviewed demonstrated that there is the capability of the tra-
ditional point-of-care troponin to be used in CDSS.16 However, there 
were issues reported with the test used in this study, including device 
errors, inability to obtain blood, and the risk of false negatives when 
samples were taken shortly after symptom onset. The study was also 
limited by the use of a single troponin value in isolation, where clini-
cians are unable to observe any trends and a raised troponin does not 
always indicate myocardial ischemia but may be a result of myocardial 
injury.27 A computer-based machine learning algorithm for the diag-
nosis of MI has been developed with a paired troponin, analyzing the 
rate of change of troponin along with age and sex showing strong sensi-
tivity at 97.8% and specificity of 92.2%.39 However, the study required 
a second troponin at 1–3 hours following the initial troponin meas-
urement and therefore would not be feasible in the prehospital envi-
ronment. The value of an isolated troponin in the prehospital situation 
maybe more apparent in combination with other components of CDSS 
such as patient history and suggestive ECG features. In addition, the 
use of prehospital high-sensitivity troponin tests in comparison to the 
inhospital test may aid in the sensitivity when identifying ACS where 
shorter time from symptom onset to test can reduce sensitivity.40
The use of contemporary risk stratification algorithms for MI 
has been shown to be effective following hospital admission, with 
examples like the History, ECG, Age, Risk factors, Troponin (HEART) 
score, Thrombolysis in Myocardial Infarction (TIMI) score and Global 
Registry of Acute Coronary Events (GRACE) score.41–43 Two stud-
ies16,35 used the HEART score as the clinical decision algorithm to aid 
in ACS risk stratification, with 1 study35 modifying the score with the 
use of a high-sensitivity troponin rather than the conventional fourth-
generation troponin measurement. Although there was excellent sen-
sitivity (100%) and negative predictive value (100%) for the modified 
HEART score algorithm, specificity (43%) and positive predictive 
value (29%) were less accurate. This could be due to the designation of 
intermediate and high values in the modified HEART scores as a “pos-
itive” score in this review. When adjusting for only the high scores on 
the modified HEART algorithm, then specificity increases to 87% and 
positive predictive value to 51%. As the authors acknowledge, the main 
objective of the HEART score is to rule-out rather than rule-in ACS; 
however, the risk stratification element could aid the rapid transfer of 
high-risk patients to specialist cardiac facilities.35
The greatest area for future development in CDSS is with 
computer-aided interpretation. Three of the CDSS in this review in-
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the final clinical decision.20,30,34 The accuracy of MI diagnosis is seen 
in the 2 studies that utilized computer-aided interpretation of ECG, 
with high specificity (100% and 99%) and positive predictive value 
(100% and 83%).20,34,44 However, 1 study which looked only at the 
digital ECG for the decision support had lower sensitivity (58%) and 
negative predictive value (30%).20 The use of computer-aided deci-
sion-making is a rapidly developing field with advances in radiology 
and pathology especially.45 However, the role of computer-aided de-
cision-making in ECG interpretation has been previously reported 
with varying sensitivity and specificity.46,47 Deep learning techniques 
for ECG interpretation have enormous potential to improve ECG 
ACS detection with the ability to detect subtle signs of ischemia and 
continually learn from their findings.48
Computer-aided decision-making was not only limited to 
ECG interpretation. One study looked at the use of a computer-
aided decision system for medical dispatch to patients presenting 
with chest pain, with the only component being patient history, and 
it found good sensitivity (92%) and negative predictive value (97%) 
but poor specificity (41%) and positive predictive value (17%).30 
The use of a computer-aided decision system can help assimilate a 
large amount of data when assessing a patient and help prioritize 
patients dependent on certain features in the history and risk factors. 
Innovations in computerized ACS diagnosis highlight the potential of 
machine learning where constant refinement of the algorithm accu-
racy can produce increasingly accurate decisions.39
This use of computer-aided decision systems in the prehospital 
setting can be advantageous, where often there is no experienced car-
diologist present and paramedic crews, with limited training, may 
have to interpret the clinical situation and ECG alone.47 The one 
study which had the computer ECG interpretation with combina-
tion of a clinical screening tool led to high sensitivity (86.9%) and 
specificity (98.5%) suggesting that an integrated approach with other 
components could be beneficial.34
Limitations
There are several important limitations with this study. Due 
to the high volume of ACS research, and in combination with the 
broad-search strategy, there is a possibility that some literature has 
been missed. This search strategy was employed to aid the identifica-
tion of studies that examined principle components, such as patient 
history within CDSS, before the adoption of new technologies, such 
as prehospital ECG and biomarkers.
The considerable heterogeneity in CDSS which limited the 
statistical analyses that could be done, particularly with 1 study con-
tributing 98% of the population for statistical analysis, hence the 
results must be taken with caution. In addition, MI was variously 
defined using the published universal definitions of MI,16,30,32,34,35 
a combination of an ECG and biomarker criteria31,33 or by ECG 
alone.20 There was a notable variation in the incidence of ACS, rang-
ing from 0.02%31 to 50%.20 This was due to patient selection for 
analysis, with the first study having included all patients present-
ing to emergency services (n = 347,989), whereas the second study 
focused exclusively on prehospital transmitted ECGs suspected of 
STEMI (n = 200) and therefore targeted a select patient group with 
a higher incidence of ACS.
Despite this, the review was able to document the nature and 
extent of the heterogeneity of the studies, including the components 
of CDSS and the methods used to examine them. It also provided 
the opportunity to examine what components were important in the 
prehospital diagnosis of ACS, and to compare the value of individual 
components and combinations thereof.
Further Research
Further research would be useful to assess the accuracy of the 
high sensitivity of CDSS involving multiple components combined 
with the high specificity of computer-aided decision systems. CDSS 
research requires further validation in different clinical environments 
TABLE 2. Results of the Analysis of the Outcomes, Sensitivities, Specificity, PPV, and NPV of the Individual Studies
Study Primary Outcome Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Grijseels et al33 Diagnosis of ACS 97.0 13. 52.0 92.0
Bruins et al32 ACS diagnosis 97.0 10.0 23.0 92.0
Bhalla et al20 STEMI diagnosis 58.0 100.0 100.0 30.0
Wilson et al34 STEMI diagnosis 86.9 98.5 83.3 98.6
Gellerstedt et al30 ACS 92.2 41.0 17.0 97.0
Sakai et al31 STEMI diagnosis 83.3 88.1 6.7 99.8
Ishak et al35 MACE* 100.0 43.0 28.5 100.0
Van Dongen et al16 MACE* within 45 d 96.0 29.0 21.0 97.0
*MACE (major adverse cardiovascular event) defined as death (all cause), MI, primary cutaneous intervention, coronary artery bypass grafting, or all-cause mortality.
NPV, negative predictive value; PPV, positive predictive value.
TABLE 3. Mean of Combined Clinical Decision Support Systems Accuracy With Incorporated Components
 
Involved ECG Involved History Involved Biomarkers Involved Examination/Vital Signs*
Mean ± SD (%) P Mean ± SD (%) P Mean ± SD (%) P Mean ± SD (%) P
Sensitivity 86.9 ± 15.5 0.531* 93.2 ± 6.1 0.002 98.0 ± 2.8 0.306* 94.7 ± 6.5 0.122
Specificity 61.9 ± 38.2 0.262* 46.1 ± 34.7 0.197* 36.0 ± 9.9 0.274 36.6 ± 31.6 0.117*
PPV 48.6 ± 36.8 0.339* 33.1 ± 26.1 0.054* 24.7 ± 5.3 0.462* 26.2 ± 16.5 0.101*
NPV 86.2 ± 27.7 0.703* 96.6 ± 3.4 0.000† 98.5 ± 2.1 0.526* 96.1 ± 4.0 0.256
*Equal variance assumed by Levene’s test for heteroscedasticity.
†Statistical significance (2-tailed) for component accuracy in model inclusion compared to omission.
PPV, positive predictive value; NPV negative predictive value.
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before CDSS are deployed for widespread use. In addition, impact 
analysis also helps judge whether the beneficial effects of CDSS would 
remain once fully incorporated into clinical use. Other effects that 
CDSS have on users need to be explored, including automation bias 
where the clinician can overtrust the decision aid.49 The user interface 
design of CDSS is another area that needs further research. Human 
factors and interaction design guidelines are often ignored in designing 
CDSS.50 However, 1 study used human–computer interaction design 
principles to design CDSS to aid ECG interpretation.51 They used eye-
tracking analysis of ECG interpretation52 and their understanding of 
human cognition and working memory to breakdown the ECG inter-
pretation process into manageable tasks on CDSS to eventually pre-
sent multiple automated diagnoses to prevent automation bias and to 
encourage differential decision-making. While CDSS are mostly con-
cerned with the provision of algorithmic text-based suggestions, future 
study may also involve better use of intelligent dynamic graphics as 
part of the algorithmic output for depicting more spatiotemporal data 
to augment the decision support.53 Finally, new studies that evaluate di-
agnostic CDSS would ideally focus on sensitivity, specificity, positive 
predictive value and negative predictive value of CDSS algorithms and 
use consistent definitions of MI. Studies that also use consistent defini-
tions and outcomes between them would help with the development 
of a successful CDSS algorithm that integrate multiple components to 
provide an effective clinical aid.
Summary
CDSS are increasingly prevalent in healthcare and in combi-
nation with computer-aided decision and point-of-care biomarkers, 
they could provide a way of improving the accuracy of prehospital 
diagnosis and outcomes of treatment. With risks associated with 
delayed treatment of ACS and, alternatively, pressures on hospital re-
sources such as cardiac cath-lab activation, there is an opportunity 
to create an efficient and safe diagnostic pathway before hospital ad-
mission. This review has highlighted the importance of patient his-
tory in diagnosis but also the potential for combining components 
such as biomarkers and computer-aided decision ECG interpretation 
in the integration of CDSS for suspected ACS.
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